Daniel Javitt
Daniel Javitt
Departments of Psychiatry and Neuroscience, Nathan Kline Institute & Columbia University
Potvrđena adresa e-pošte na
Recent advances in the phencyclidine model of schizophrenia.
DC Javitt, SR Zukin
The American journal of psychiatry 148 (10), 1301-1308, 1991
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
JE Lisman, JT Coyle, RW Green, DC Javitt, FM Benes, S Heckers, ...
Trends in neurosciences 31 (5), 234-242, 2008
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment
B Moghaddam, D Javitt
Neuropsychopharmacology 37 (1), 4-15, 2012
Multisensory auditory–visual interactions during early sensory processing in humans: a high-density electrical mapping study
S Molholm, W Ritter, MM Murray, DC Javitt, CE Schroeder, JJ Foxe
Cognitive brain research 14 (1), 115-128, 2002
The NKI-Rockland sample: a model for accelerating the pace of discovery science in psychiatry
KB Nooner, SJ Colcombe, RH Tobe, M Mennes, MM Benedict, AL Moreno, ...
Frontiers in neuroscience 6, 152, 2012
Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments
LA Ross, D Saint-Amour, VM Leavitt, DC Javitt, JJ Foxe
Cerebral cortex 17 (5), 1147-1153, 2007
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
DC Javitt, M Steinschneider, CE Schroeder, JC Arezzo
Proceedings of the National Academy of Sciences 93 (21), 11962-11967, 1996
Glutamate and schizophrenia: phencyclidine, N‐methyl‐d‐aspartate receptors, and dopamine–glutamate interactions
DC Javitt
International review of neurobiology 78, 69-108, 2007
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia
D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt
Archives of general psychiatry 57 (12), 1139-1147, 2000
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
Molecular psychiatry 9 (11), 984-997, 2004
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
U Heresco-Levy, DC Javitt, M Ermilov, C Mordel, G Silipo, M Lichtenstein
Archives of general psychiatry 56 (1), 29-36, 1999
When doors of perception close: bottom-up models of disrupted cognition in schizophrenia
DC Javitt
Annual review of clinical psychology 5, 249-275, 2009
Automated analysis of free speech predicts psychosis onset in high-risk youths
G Bedi, F Carrillo, GA Cecchi, DF Slezak, M Sigman, NB Mota, S Ribeiro, ...
npj Schizophrenia 1 (1), 1-7, 2015
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments
RW Buchanan, DC Javitt, SR Marder, NR Schooler, JM Gold, ...
American Journal of Psychiatry 164 (10), 1593-1602, 2007
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?
JT Kantrowitz, DC Javitt
Brain research bulletin 83 (3-4), 108-121, 2010
Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study
MJ Hoptman, XN Zuo, PD Butler, DC Javitt, D D'Angelo, CJ Mauro, ...
Schizophrenia research 117 (1), 13-20, 2010
Multisensory auditory–somatosensory interactions in early cortical processing revealed by high-density electrical mapping
JJ Foxe, IA Morocz, MM Murray, BA Higgins, DC Javitt, CE Schroeder
Cognitive Brain Research 10 (1-2), 77-83, 2000
Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study
JJ Foxe, GR Wylie, A Martinez, CE Schroeder, DC Javitt, D Guilfoyle, ...
Journal of neurophysiology 88 (1), 540-543, 2002
Grabbing your ear: rapid auditory–somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment
MM Murray, S Molholm, CM Michel, DJ Heslenfeld, W Ritter, DC Javitt, ...
Cerebral cortex 15 (7), 963-974, 2005
Amelioration of negative symptoms in schizophrenia by glycine.
DC Javitt, I Zylberman, SR Zukin, U Heresco-Levy, JP Lindenmayer
The American journal of psychiatry 151 (8), 1234-1236, 1994
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20